Average Co-Inventor Count = 4.37
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (21 from 669 patents)
2. Incyte Holdings Corporation (3 from 147 patents)
3. Incyte Holdings Cororation (1 from 1 patent)
21 patents:
1. 12415809 - Pyrrolotriazine compounds as tam inhibitors
2. 12060433 - CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy
3. 11884665 - Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
4. 11767320 - Bicyclic dione compounds as inhibitors of KRAS
5. 11673894 - Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
6. 11390624 - Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
7. 11285140 - Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
8. 11220510 - Pyrrole tricyclic compounds as A2A / A2B inhibitors
9. 10695337 - Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
10. 10053465 - Pyrrolopyrimidine derivatives as TAM inhibitors
11. 10000507 - Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
12. 9999619 - Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
13. 9556197 - Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
14. 9464088 - Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
15. 9067921 - Piperazinylpiperidine derivatives as chemokine receptor antagonists